ライフサイエンスコーパス: catheterization laboratory

1 Gs consistent with STEMI were triaged to the catheterization laboratory.

2 ducing a second anticoagulant in the cardiac catheterization laboratory.

3 fits from therapies available in the cardiac catheterization laboratory.

4 se patients were successfully treated in the catheterization laboratory.

5 rgery and by subendocardial injection in the catheterization laboratory.

6 mergency room or later administration in the catheterization laboratory.

7 dy supports the routine use of RADPAD in the catheterization laboratory.

8 fraction <40% had dobutamine infusion in the catheterization laboratory.

9 to inhaled nitric oxide (iNO) in the cardiac catheterization laboratory.

10 All defects were closed in the catheterization laboratory.

11 facilitates the reduction of exposure in the catheterization laboratory.

12 ction on-line of myocardial viability in the catheterization laboratory.

13 he potential of this approach in the cardiac catheterization laboratory.

14 results have important implications for the catheterization laboratory.

15 patients, in 2 of the 4 before they left the catheterization laboratory.

16 ry artery disease encountered in the cardiac catheterization laboratory.

17 elpful in the diagnosis of CP in the cardiac catheterization laboratory.

18 perfusion can only be performed outside the catheterization laboratory.

19 ion before coronary angiography, outside the catheterization laboratory.

20 tory facilities, bronchoscopy, and a cardiac catheterization laboratory.

21 09-2.58; p = 0.02) compared with the cardiac catheterization laboratory.

22 s as to why we still need BMS in our cardiac catheterization laboratory.

23 in participants ascertained via the cardiac catheterization laboratory.

24 rdiopulmonary bypass or interventions in the catheterization laboratory.

25 ement of CI-AKI as it applies to the cardiac catheterization laboratory.

26 ot be recommended for decision making in the catheterization laboratory.

27 patients prior to activation of the cardiac catheterization laboratory.

28 ion are not readily available in the cardiac catheterization laboratory.

29 %) had a measurable pressure gradient in the catheterization laboratory.

30 are transferable to actual procedures in the catheterization laboratory.

31 proaches of late or no access to the cardiac catheterization laboratory.

32 nd more than one-half do not have a coronary catheterization laboratory.

33 ly performed post-operatively in the cardiac catheterization laboratory.

34 and most U.S. hospitals do not have cardiac catheterization laboratories.

35 for 10 years; 3) the hospital had a cardiac catheterization laboratory; 4) costs of night call for t

36 he median OxPL/apoB presented to the cardiac catheterization laboratory a mean of 3.9 years earlier (

37 Use of FFR in the catheterization laboratory accurately identifies which l

38 ian (IQR) time from first medical contact to catheterization laboratory activation (30 [12-42] minute

39 y care processes increased after prehospital catheterization laboratory activation (62%-91%; P<0.001)

40 levation myocardial infarction diagnosis and catheterization laboratory activation (door-to-activatio

41 PCI hospitals agreed to provide single-call catheterization laboratory activation by emergency medic

42 point was the time from hospital arrival to catheterization laboratory activation by the emergency d

43 mmunity and rural hospitals with pretransfer catheterization laboratory activation for percutaneous c

44 The frequency of false-positive cardiac catheterization laboratory activation for suspected STEM

45 ed data on the frequency of "false-positive" catheterization laboratory activation in patients underg

46 Prevalence of false-positive catheterization laboratory activation in patients with s

47 ), a first medical contact to device time to catheterization laboratory activation of </=20 minutes (

48 l infarction networks focused on prehospital catheterization laboratory activation, single call trans

49 to increased rates of false-positive cardiac catheterization laboratory activation, unnecessary risks

50 consider the consequences of false-positive catheterization laboratory activation.

51 ography, and higher residual gradient in the catheterization laboratory after ASA (all P<0.05).

52 al electrocardiograms (ECGs) to activate the catheterization laboratory, allowing emergency physician

53 tricular fibrillation (VT/VF) in the cardiac catheterization laboratory among patients undergoing pri

54 te was lower at facilities with small-volume catheterization laboratories and was not associated with

55 gency department physician activation of the catheterization laboratory and (2) immediate transfer of

56 iac ARIA 1A locations (hospital with cardiac catheterization laboratory and all aftercare within 1 ho

57 ances in radiation protection in the cardiac catheterization laboratory and discuss the effectiveness

58 Clopidogrel (300 mg) was administered in the catheterization laboratory and followed by 75 mg daily.

59 gency department physician activation of the catheterization laboratory and immediate transfer of the

60 ions to guide decision-making in the cardiac catheterization laboratory and improve clinical outcomes

61 me, in the outpatient clinic, in the cardiac catheterization laboratory and in the intensive care uni

62 Combining the tools of the catheterization laboratory and operating room greatly en

63 The residual LVOT gradient in the catheterization laboratory and peak CK leak after ASA ar

64 Vanderbilt University Medical Center cardiac catheterization laboratory and performed DNA sequencing

65 ference between the patient's arrival at the catheterization laboratory and the patient's final angio

66 infarction, including time of arrival in the catheterization laboratory and time of first balloon inf

67 chemia will be the gatekeeper to the cardiac catheterization laboratory and will transform the world

68 hat had weak or no regulation of new cardiac catheterization laboratories, and in wealthier and large

69 received anesthesia in the pediatric cardiac catheterization laboratory, and 51 were deeply sedated i

70 llowing emergency physicians to activate the catheterization laboratory, and substantial interdiscipl

71 gency medical systems, emergency department, catheterization laboratory, and transfer.

72 nt, Emergency Medical System and the Cardiac Catheterization Laboratory; and 4) Regional STEMI system

73 onal procedures in the electrophysiology and catheterization laboratory are rapidly advancing.

74 nt of coronary artery disease in the cardiac catheterization laboratory are reviewed.

75 e (25th-75th percentiles) from ED arrival to catheterization laboratory arrival was 30 (20-41) minute

76 minus the time between hospital arrival and catheterization laboratory arrival.

77 95% CI: 1.065 to 2.069), and treatment in a catheterization laboratory as opposed to hybrid operatin

78 ta support clopidogrel administration in the catheterization laboratory as the standard of care.

79 analyses, when there was an existing cardiac catheterization laboratory at a hospital with > or = 200

80 We included all patients presenting to the catheterization laboratory at our institution after PMI

81 od predicts periprocedural MI in the cardiac catheterization laboratory before it occurs.

82 spirin point-of-care assays were used in the catheterization laboratory before stent implantation and

83 unctional LVOT conduit were evaluated in the catheterization laboratory between December 2008 and Aug

84 ty improvement activity performed in cardiac catheterization laboratories, but best practices for cas

85 exists about whether hospitals with cardiac catheterization laboratories, but without onsite cardiac

86 r of the patient to an immediately available catheterization laboratory by an in-house transfer team

87 hospital ECGs, prehospital activation of the catheterization laboratory, bypassing geographically clo

88 The catheterization laboratory can be used to provide diagno

89 al treatment, or nothing) recommended by the catheterization laboratory cardiologist for patients und

90 e found to have coronary artery disease, the catheterization laboratory cardiologist was the final so

91 Catheterization laboratory cardiologists in hospitals wi

92 , Reporting, and Tracking System for Cardiac Catheterization Laboratories (CART-CL) program.

93 Catheterization laboratory (cath lab) activation time is

94 The end points included patency rates on catheterization laboratory (cath lab) arrival, technical

95 sfer from the STEMI referral hospital to the catheterization laboratory (cath lab) at the STEMI recei

96 inhibitors before angiography and 591 in the catheterization laboratory (cath lab).

97 copic exposure rates in contemporary cardiac catheterization laboratories (CCL).

98 ent elevation myocardial infarction, cardiac catheterization laboratory (CCL) activation by emergency

99 vel protocol of early transport to a cardiac catheterization laboratory (CCL) for extracorporeal life

100 Rapid activation of a cardiac catheterization laboratory (CCL) has reduced door-to-bal

101 The procedural success rate without major catheterization laboratory complications was similar in

102 edian, $13,809), $6,515 of which represented catheterization laboratory costs.

103 The use of these microbubbles in the cardiac catheterization laboratory could, therefore, provide fur

104 510) with ISR were identified using cardiac catheterization laboratory data.

105 A cardiac catheterization laboratory database used by 19 hospitals

106 ronary heart disease from coronary units and catheterization laboratories, direct mail to age-eligibl

107 left ventricular hemodynamics in the cardiac catheterization laboratory during EECP.

108 ation) and those transported directly to the catheterization laboratory (ED bypass).

109 le has expanded to include procedures in the catheterization laboratory, electrophysiology suite, ope

110 Particular adaptations to the cardiac catheterization laboratory environment are required to a

111 varying assumptions about whether a cardiac catheterization laboratory exists, whether services are

112 and pressure can be obtained in the cardiac catheterization laboratory, facilitating physiologically

113 sociated with hospital size, remoteness, and catheterization laboratory facilities.

114 pulmonary resuscitation [CPR] to the cardiac catheterization laboratory for ECPR) compared with 654 a

115 Subjects were brought back to the catheterization laboratory for guide wire crossing and a

116 ecutive patients referred to the Mayo Clinic catheterization laboratory for hemodynamic assessment be

117 tcomes in patients presenting to the cardiac catheterization laboratory for myocardial infarction sus

118 he integration of coronary physiology in the catheterization laboratory for optimal patient outcomes.

119 32 patients representing 13,061 trips to the catheterization laboratory for percutaneous transluminal

120 g for patient triage directly to the cardiac catheterization laboratory from the field.

121 ith bivalirudin monotherapy or bivalirudin + catheterization laboratory GPI (p = 0.02).

122 f coronary artery disease in patients in the catheterization laboratory has become increasingly impor

123 Development of the "all-digital" cardiac catheterization laboratory has been slowed by substantia

124 e use of invasive coronary physiology in the catheterization laboratory has demonstrated favorable ou

125 al-time measurement of lung perfusion at the catheterization laboratory has the potential to reduce u

126 time from STEMI diagnosis to arrival at the catheterization laboratory have been widely investigated

127 ambulance (ambulance group, n=127) or in the catheterization laboratory (hospital group, n=129).

128 ory angina are often referred to the cardiac catheterization laboratory; however, they have often exh

129 s classified according to PCI center status (catheterization laboratory immediately accessible 24/7).

130 data on all CAs and PCIs performed in the 36 catheterization laboratories in the Greater Paris Area,

131 s data from approximately 85% of the cardiac catheterization laboratories in the United States.

132 s included stent embolizations stabilized in catheterization laboratory in 2 patients, left innominat

133 In a high-volume cardiac catheterization laboratory in a large, nonuniversity tea

134 l process for developing an HOR in a cardiac catheterization laboratory in a VA designated for comple

135 rials have clarified the role of the cardiac catheterization laboratory in the management of resuscit

136 ompared pretreatment versus treatment in the catheterization laboratory (In-Cathlab) in a real-world

137 In the catheterization laboratory, intravascular imaging provid

138 department physician to activate the cardiac catheterization laboratory is a key strategy to reduce d

139 these patients, early access to the cardiac catheterization laboratory is associated with a 10% to 1

140 n, we conclude that pregnancy in the cardiac catheterization laboratory is both safe and feasible.

141 X-ray use in the catheterization laboratory is guided by the principle of

142 e incidence of CIHB in the pediatric cardiac catheterization laboratory is low at 2.2%.

143 in a large number of patients in the cardiac catheterization laboratory, is increasingly used for dec

144 ography or deferred for selective use in the catheterization laboratory just prior to angioplasty.

145 es from intensive care units for the cardiac catheterization laboratory (lower by 0.44 percentage poi

146 site visit consisting of a National Chief of Catheterization Laboratory Managers, a cardiac surgeon,

147 ts with high-risk AMI at hospitals without a catheterization laboratory may have an improved outcome

148 department (ED) with direct transport to the catheterization laboratory may shorten reperfusion times

149 g emergency medicine physicians activate the catheterization laboratory (mean reduction in door-to-ba

150 = 346, 97%); single phone call activation of catheterization laboratory (N = 335, 92%); emergency dep

151 If a new cardiac catheterization laboratory needed to be built, costs wou

152 for selective administration in the cardiac catheterization laboratory only to patients undergoing p

153 number of clinicians are using a strategy of catheterization laboratory-only eptifibatide (an off-lab

154 A catheterization laboratory-only eptifibatide regimen is

155 We used optimal matching to link the use of catheterization laboratory-only eptifibatide with clinic

156 alysis, compared with bolus plus infusion, a catheterization laboratory-only regimen was associated w

157 Of these, a catheterization laboratory-only regimen was used in 4511

158 olus plus infusion with those treated with a catheterization laboratory-only regimen.

159 at the time of CABG performed in the hybrid catheterization laboratory/operating room.

160 be transferred to an intensive care unit, a catheterization laboratory or an operating room for furt

161 l procedures were performed within a cardiac catheterization laboratory or hybrid operating room unde

162 patients, after exclusions from death in the catheterization laboratory or immediately on intensive c

163 procedural predictors were total time in the catheterization laboratory or operating room, delivery c

164 The interventions did not increase catheterization laboratory or postprocedural complicatio

165 In the catheterization laboratory, physiologically significant

166 The cardiac catheterization laboratory plays an important role in th

167 total occlusions are common in contemporary catheterization laboratory practice.

168 procedure, intraprocedure, and postprocedure catheterization laboratory practices where evidence has

169 At hospitals with an existing cardiac catheterization laboratory, primary angioplasty for acut

170 is potentially applicable as a percutaneous catheterization laboratory procedure for the treatment o

171 Four-hundred consecutive patients undergoing catheterization laboratory procedures were randomly assi

172 The catheterization laboratory protocol provides a model to

173 Measurements of coronary physiology in the catheterization laboratory provide objective data that c

174 o-invasive strategy, and the risk of cardiac catheterization laboratory provider infection remained v

175 r of the patient to an immediately available catheterization laboratory reduce door-to-balloon time,

176 ach utilizes hospital facilities outside the catheterization laboratory, requiring additional time an

177 isplaying the safe contrast limit to cardiac catheterization laboratory staff prior to percutaneous c

178 s, and scene departure to patient on cardiac catheterization laboratory table </=30 minutes.

179 e from scene departure to arrival on cardiac catheterization laboratory table of </=30 minutes were 1

180 and early and consistent availability of the catheterization laboratory team.

181 revascularization is now commonplace in the catheterization laboratory, the presence of a CTO provid

182 citation, and endotracheal intubation in the catheterization laboratory, their in-hospital and one-ye

183 ice transport from the field directly to the catheterization laboratory, thereby bypassing the emerge

184 siological coronary lesion assessment in the catheterization laboratory, thereby potentially leading

185 In the catheterization laboratory three techniques can be used

186 on, LVOT gradient reduction after ASA in the catheterization laboratory to > or =25 mm Hg (OR, 5.5; P

187 nctional information that can be used in the catheterization laboratory to designate patients to the

188 the median time from arrival in the cardiac catheterization laboratory to first balloon was 27 minut

189 lar approach could be applied in the cardiac catheterization laboratory to protect reperfused myocard

190 ources, such as the number of hospitals with catheterization laboratories, trained personnel, and the

191 in the ambulance) versus in-hospital (in the catheterization laboratory) treatment with ticagrelor.

192 ng staff in the emergency department and the catheterization laboratory use real-time data feedback (

193 ical measurements can be made in the cardiac catheterization laboratory using sensor-tipped guidewire

194 spite this, practice patterns in the cardiac catheterization laboratory vary across health systems, a

195 with P2Y12 inhibitors, before arrival to the catheterization laboratory, was not associated with impr

196 CART) program representing all 76 VA cardiac catheterization laboratories, we evaluated all patients

197 having the emergency department activate the catheterization laboratory while the patient is en route

198 uded all invasive cardiologists at 3 cardiac catheterization laboratories who were randomized to vari

199 nt 'Fontan' procedure to be completed in the catheterization laboratory with a covered stent.

200 ynamic measurements were made in the cardiac catheterization laboratory with a Swan-Ganz thermodiluti

201 on of ANOCA noninvasively and in the cardiac catheterization laboratory with coronary function testin

202 hic examinations at baseline, acutely in the catheterization laboratory with ethanol injection and at

203 ty-nine patients were studied in the cardiac catheterization laboratory with simultaneous Doppler ech

204 Interventional cardiologists at 2 cardiac catheterization laboratories within the same health syst

205 4 minutes), expecting staff to arrive in the catheterization laboratory within 20 minutes after being

206 nd interventional studies in the Mayo Clinic catheterization laboratory within an eight week period i